121 related articles for article (PubMed ID: 37710976)
1. Reference intervals for deconjugated urine metanephrines by Bhattacharya analysis.
Li B; King R; Sies C; Thompson S; Florkowski C
Ann Clin Biochem; 2024 May; 61(3):173-181. PubMed ID: 37710976
[TBL] [Abstract][Full Text] [Related]
2. Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models.
Doyle K; Frank EL
Am J Clin Pathol; 2021 Sep; 156(4):691-699. PubMed ID: 33880513
[TBL] [Abstract][Full Text] [Related]
3. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
[TBL] [Abstract][Full Text] [Related]
4. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
[TBL] [Abstract][Full Text] [Related]
5. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
[TBL] [Abstract][Full Text] [Related]
6. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
Bokuda K; Yatabe M; Seki Y; Ichihara A
Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
[TBL] [Abstract][Full Text] [Related]
8. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract][Full Text] [Related]
9. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Peitzsch M; Kaden D; Langton K; Mangelis A; Pamporaki C; Masjkur J; Geroula A; Kurlbaum M; Deutschbein T; Beuschlein F; Prejbisz A; Bornstein SR; Lenders JWM
Clin Chim Acta; 2019 Mar; 490():46-54. PubMed ID: 30571948
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
[TBL] [Abstract][Full Text] [Related]
11. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
[TBL] [Abstract][Full Text] [Related]
12. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry.
Willemsen JJ; Ross HA; Wolthers BG; Sweep CG; Kema IP
Ann Clin Biochem; 2001 Nov; 38(Pt 6):722-30. PubMed ID: 11732660
[TBL] [Abstract][Full Text] [Related]
14. Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytoma.
Pamporaki C; Därr R; Bursztyn M; Glöckner S; Bornstein SR; Lenders JW; Pacak K; Krinner A; Eisenhofer G
Clin Endocrinol (Oxf); 2013 Oct; 79(4):476-83. PubMed ID: 23461656
[TBL] [Abstract][Full Text] [Related]
15. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
[TBL] [Abstract][Full Text] [Related]
16. Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis.
Xiong X; Zhang Y
Anal Bioanal Chem; 2020 May; 412(12):2763-2775. PubMed ID: 32130439
[TBL] [Abstract][Full Text] [Related]
17. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma.
Gardet V; Gatta B; Simonnet G; Tabarin A; Chêne G; Ducassou D; Corcuff JB
J Hypertens; 2001 Jun; 19(6):1029-35. PubMed ID: 11403350
[TBL] [Abstract][Full Text] [Related]
18. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
Peaston RT; Lennard TW; Lai LC
J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
[TBL] [Abstract][Full Text] [Related]
19. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma.
Taylor RL; Singh RJ
Clin Chem; 2002 Mar; 48(3):533-9. PubMed ID: 11861444
[TBL] [Abstract][Full Text] [Related]
20. Symptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offs.
Cho YY; Song KH; Kim YN; Ahn SH; Kim H; Park S; Suh S; Kim BJ; Lee SY; Chun S; Koh JM; Lee SH; Kim JH
Endocrine; 2016 Oct; 54(1):206-216. PubMed ID: 27481364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
